Literature DB >> 21154038

Nonverbal memory tasks in early differential diagnosis of Alzheimer's disease and unipolar depression.

Israel Contador1, Bernardino Fernandez-Calvo, Jesus Cacho, Francisco Ramos, Alex Lopez-Rolon.   

Abstract

We examined whether there are selective deficits in early-stage Alzheimer's disease (AD; n = 27) and in unipolar depression (UD; n = 17) patients on recall and recognition of spatial and visual components of nonverbal memory (NVM) and whether the two groups can be differentiated based on their performance on such tasks. We also investigated which NVM measures had the best discrimination power. We tested spatial, visuospatial, and visuoconstructive abilities in AD and UD patients. AD patients' scores on NVM tasks were significantly lower than those of healthy subjects (HS; n = 30) and consistently lower than those of the UD group. Z-scores suggested that AD patients suffered from a generalized impairment. Clear differences between AD and UD patients were found on abstract design tasks.

Entities:  

Mesh:

Year:  2010        PMID: 21154038     DOI: 10.1080/09084282.2010.525098

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  3 in total

1.  Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer's Disease.

Authors:  Kimberly D Mueller; Lianlian Du; Davide Bruno; Tobey Betthauser; Bradley Christian; Sterling Johnson; Bruce Hermann; Rebecca Langhough Koscik
Journal:  Front Psychol       Date:  2022-06-27

2.  Depression and episodic memory across the adult lifespan: A meta-analytic review.

Authors:  Taylor A James; Samuel Weiss-Cowie; Zachary Hopton; Paul Verhaeghen; Vonetta M Dotson; Audrey Duarte
Journal:  Psychol Bull       Date:  2021-11       Impact factor: 23.027

3.  Story Memory Impairment Rates and Association with Hippocampal Volumes in a Memory Clinic Population.

Authors:  Christina G Wong; Sharlene L Jeffers; Samantha A Bell; Jessica Z K Caldwell; Sarah J Banks; Justin B Miller
Journal:  J Int Neuropsychol Soc       Date:  2021-06-30       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.